{"podcast":{"title":"Pro Tennis News Today | 2 Min News | The Daily News Now!","slug":"pro-tennis-news-today-2-min-news-the-daily-news-now-7492299","podcast_index_feed_id":7492299,"rss_url":"https://feeds.fastcast.ai/pro-tennis-today-2-min-news.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/pro-tennis-today-2-min-news.jpg","author":"The Daily News Now!","episode_count":47,"summary":"Hosted by Corey with the Story, Pro Tennis News Today delivers daily coverage of the professional tennis world with fast, focused updates on tournaments, player performances, rankings, and key storylines across the ATP and WTA tours. From Grand Slams to global events, the show keeps fans locked in on everything happening in tennis. Each short episode highlights what matters most—including match results, rankings movement, and tournament trends—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, Pro Tennis News Today is built for fans who want reliable tennis coverage in a quick, easy-to-digest format. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-14T04:20:33.104831+00:00","page_url":"https://stenobird.com/podcast/pro-tennis-news-today-2-min-news-the-daily-news-now-7492299"},"episode":{"title":"Serena Williams and the GLP-1 Debate","slug":"serena-williams-and-the-glp-1-debate","published_at":"2026-06-01T16:04:23+00:00","page_url":"https://stenobird.com/podcast/pro-tennis-news-today-2-min-news-the-daily-news-now-7492299/serena-williams-and-the-glp-1-debate","show_page_url":"https://stenobird.com/podcast/pro-tennis-news-today-2-min-news-the-daily-news-now-7492299","url":"https://api.fastcast.ai/audio/93a24b80-cf24-4ef2-af35-6d135265b579.mp3","audio_url":"https://api.fastcast.ai/audio/93a24b80-cf24-4ef2-af35-6d135265b579.mp3","summary":"Serena Williams is back on the court—and with her, a heated debate about GLP-1 weight-loss drugs like Zepbound. Partnering with Ro, she’s candid about losing 34 pounds and regaining energy, but her use sparks controversy as WADA watches these meds closely. Not banned yet, but under scrutiny—could they give athletes an edge? Her personal journey fuels the conversation as she navigates fitness, performance, and the science behind these controversial treatments. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/66f657b8ebbb9437","meta_description":"Serena Williams is back on the court—and with her, a heated debate about GLP-1 weight-loss drugs like Zepbound. Partnering with Ro, she’s candid about los…","key_points":[],"chapters":[],"topics":[],"duration_seconds":116,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/pro-tennis-news-today-2-min-news-the-daily-news-now-7492299/episodes/serena-williams-and-the-glp-1-debate/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/pro-tennis-news-today-2-min-news-the-daily-news-now-7492299/serena-williams-and-the-glp-1-debate.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}